Skip to main content
Gut logoLink to Gut
. 1985 Feb;26(2):194–197. doi: 10.1136/gut.26.2.194

Effect of glyceryl trinitrate on the sphincter of Oddi motility and baseline pressure.

M Staritz, T Poralla, K Ewe, K H Meyer zum Büschenfelde
PMCID: PMC1432421  PMID: 3917965

Abstract

It is widely accepted that glyceryl trinitrate (GTN) effectively dilates the smooth muscles of blood vessels. A similar effect has been postulated on the smooth muscles in the gastrointestinal tract. In this study the motility of the sphincter of Oddi and the common bile duct pressure as determined by endoscopic manometry was investigated in nine patients before and after sublingual application of 1.2 mg GTN (nitro group). Eight untreated patients served as controls. Three minutes after application of GTN the papillary contraction amplitude decreased from 69.3 +/- 4.3 mmHg to 36.8 +/- 5.1 mmHg (p less than 0.005) and the papillary baseline pressure fell from 8.9 +/- 0.6 mmHg to 2.9 +/- 0.2 mmHg (p less than 0.005) respectively. The contraction frequency in the nitro group and all motility parameters in the control group remained unchanged. These results indicate that GTN does not influence the sphincter of Oddi motility, but it relaxes very effectively the sphincter of Oddi muscle. Thus, GTN should be taken into account for the treatment of biliary colic. In our endoscopic unit GTN proved to be useful as premedication for endoscopic examinations, particularly for the removal of small and medium size common bile duct stones through the intact papilla.

Full text

PDF
194

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong P. W., Armstrong J. A., Marks G. S. Blood levels after sublingual nitroglycerin. Circulation. 1979 Mar;59(3):585–588. doi: 10.1161/01.cir.59.3.585. [DOI] [PubMed] [Google Scholar]
  2. Arndorfer R. C., Stef J. J., Dodds W. J., Linehan J. H., Hogan W. J. Improved infusion system for intraluminal esophageal manometry. Gastroenterology. 1977 Jul;73(1):23–27. [PubMed] [Google Scholar]
  3. Brandstätter G. Pharmacological pressure reduction in the human common bile duct. Z Gastroenterol. 1983 Apr;21(4):168–174. [PubMed] [Google Scholar]
  4. Geenen J. E., Hogan W. J., Dodds W. J., Stewart E. T., Arndorfer R. C. Intraluminal pressure recording from the human sphincter of Oddi. Gastroenterology. 1980 Feb;78(2):317–324. [PubMed] [Google Scholar]
  5. Greenstein A. J., Kaynan A., Singer A., Dreiling D. A. A comparative study of pentazocine and meperidine on the biliary passage pressure. Am J Gastroenterol. 1972 Oct;58(4):417–427. [PubMed] [Google Scholar]
  6. Hopton D. S., Torrance H. B. Action of various new analgesic drugs on the human common bile duct. Gut. 1967 Jun;8(3):296–300. doi: 10.1136/gut.8.3.296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kasugai T. Recent advances in the endoscopic retrograde cholangiopancreatography. Digestion. 1975;13(1-2):76–99. doi: 10.1159/000197697. [DOI] [PubMed] [Google Scholar]
  8. Nebel O. T. Manometric evaluation of the papillar of Vater. Gastrointest Endosc. 1975 Feb;21(3):126–128. doi: 10.1016/s0016-5107(75)73819-1. [DOI] [PubMed] [Google Scholar]
  9. Safrany L. Duodenoscopic sphincterotomy and gallstone removal. Gastroenterology. 1977 Feb;72(2):338–343. [PubMed] [Google Scholar]
  10. Staritz M., Ewe K., Meyer zum Büschenfelde K. H. Endoscopic papillary dilation (EPD) for the treatment of common bile duct stones and papillary stenosis. Endoscopy. 1983 May;15 (Suppl 1):197–198. doi: 10.1055/s-2007-1021507. [DOI] [PubMed] [Google Scholar]
  11. Tigerstedt I., Turunen M., Tammisto T., Hästbacka J. The effect of buprenorphine and oxycodone on the intracholedochal passage pressure. Acta Anaesthesiol Scand. 1981 Apr;25(2):99–102. doi: 10.1111/j.1399-6576.1981.tb01617.x. [DOI] [PubMed] [Google Scholar]
  12. Viceconte G. Effects of ethanol on the sphincter of Oddi: an endoscopic manometric study. Gut. 1983 Jan;24(1):20–27. doi: 10.1136/gut.24.1.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Winsor T., Berger H. J. Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic, and statistical evidence of efficacy based on a three-phase experimental design. Am Heart J. 1975 Nov;90(5):611–626. doi: 10.1016/0002-8703(75)90226-4. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES